Jubilant HollisterStier LLC, a step down subsidiary of Jubilant Pharmova, has entered into a manufacturing partnership with Ocugen, a biopharmaceutical company. This agreement is for manufacturing of vaccine candidate Covaxin for the US and Canadian markets.
The Centre hailed the Novavax vaccine against the coronavirus disease (Covid-19) and said its efficacy data is promising and encouraging. The vaccine’s clinical trials are in an advanced stage of completion in India.
The Central government on Tuesday announced that pre-registration or prior booking of appointment is not mandatory to avail the COVID-19 vaccination services.The government further said that anyone aged above 18 years or more can directly go to the nearest vaccination center where the vaccinator performs the on-site registration and administers the vaccine in the same visit.
The Centre for Cellular and Molecular Platforms (C-CAMP) and Hitachi ABB Power Grids in India have tied up to enable efficient last-mile COVID-19 vaccine delivery in South India. C-CAMP in partnership with Hitachi ABB Power Grids will provide public healthcare systems in Bengaluru, Mysuru, and Chennai with an indigenously developed, innovative, portable cold-chain transport device for efficient vaccine delivery.
A single dose of Covid-19 vaccine is sufficient for an infected person as there was a greater antibody response when compared with those who have had no prior infection,according to a study released by AIG Hospitals.
Russian Direct Investment Fund (RDIF), the agency that is spearheading Sputnik V vaccine manufacturing and supply partnerships globally, said India has become the 60th country to approve Sputnik V. “RDIF has created partnerships with a number of India’s leading pharmaceutical companies for production of Sputnik V which will provide for both vaccination of the population in India and global distribution of the Russian vaccine.
The recruitment for the clinical trial of the country’s first indigenously-developed Covid vaccine –– Covaxin, among children falling in the age group of 6-12 years will begin at the All India Institute of Medical Sciences (AIIMS), Delhi, from Tuesday, PTI reported. This will be followed by the clinical trial of 2-6 years’ children. The enrolment of children volunteers aged 12-18 years at the AIIMS has been completed and they have already been given the first dose of Covaxin.
The government’s strategy to open up Covid-19 vaccinations to children sets out a target to progressively cover 80 percent of the 130 million people falling in the 12-18 year age group.
The Central Industrial Security Force (CISF) took over the security of vaccine manufacturer Bharat Biotech’s premises in Hyderabad on Monday to protect it against any terror threat or sabotage that may lead to a biological disaster. A contingent of 64 personnel, headed by an inspector-rank officer of the paramilitary force, was inducted at a ceremony held at the Genome Valley in the Shameerpet area of Telangana’s capital city.
ICMR is looking to engage UAV operators to operate “Beyond Visual Line of Site (BVLOS)” in fixed pre-defined and pre-approved flight paths and deliver Medical Supply payloads like Vaccines and drugs to selected locations in India and return to the command station.